Is there more responsible business than pharmaceutical? After all, usually, at the heart of any commercial project is the desire to earn. How to be in a situation where entrepreneurial activity is not just a pursuit of profit, but an important social mission? Andrey Deineko - head of the pharmaceutical company Aspen in Ukraine, and in the past - a practicing surgeon, answered all these questions to business publication LDaily.
In a conversation with LDaily, CEO explained why the domestic pharmaceutical industry has increased its capacity during the crisis, and that an investor who is not afraid to enter the Ukrainian market.
A story of India native Rajeev Gupta, who was not afraid to start his business in a foreign country
Valeriy Kondruk, the president of “Pharmplaneta” company, explains why foreign pharmaceutical companies are ready to return to Ukraine only after 2025
Tetiana Pechaeva, CEO of the Lekhim group of companies, told why health care reform could fail
How business protects its interests, uniting the efforts of other companies, explained the president of the «Operators of medical products market» Association Pavlo Kharchyk in his interview
Vladimir Redko, executive director of the Association of Pharmaceutical Research and Development "APRaD" told about tendencies of health care reform
The Ukrainian pharmaceutical market has lived through difficult times, which made its players evolve to survive the crisis. Nevertheless, there were exceptions: those who were not ready to make strategic decisions - dropped out of the game. Or, on the contrary, he used crisis excitements for a new round of business development. The LDaily journalist met with Stanislav Dyachenko, the director of the STADA Representative Office in Ukraine to get to know the pharmaceutical industry from the inside and discuss how the pharmaceutical companies managed to overcome the difficult times for the industry
How the Producers of Medical Equipment and Medical Devices Committee of the American Chamber of Commerce protects the interests of foreign business in Ukraine tells Mykola Romaniok, Head of the Chamber Working Group, in an interview with LDaily
Top-management GlaxoSmithKline Pharmaceutical Ukraine (GSK) talking about culture of ethics in Ukraine pharmaceutical market
Marketing director of the company "Bionorika" Anatolii Pasichnyk tells about the pharmaceutical business, crisis, investment attractiveness of Ukraine and democratic management in the company
Managing partner of the group of companies Cratiya, LLC Maxim Bagreev about the modern ways of pharmaceutical development in the country
Head of the Board of All-Ukrainian Pharmaceutical Chamber, member of the International Pharmaceutical Federation (FIP) Oleg Klimov opened the dark side of the Ukrainian pharmacy business in a sharp as a needle interview for LDaily
Honest conversation with Mykola Siutkin, founder and CEO of S&P Investment Risk Management Agency about the different worldviews that business creates for itself.